Clik here to view.
Promedior Moves Fibrosis Pipeline to Boston, Hires Shire Vet as CEO
Arlene Weintraub Biotech firm Promedior announced today that it will be moving its headquarters from Malvern, PA, to Boston, and that it has hired a …
View ArticleStemgent, Inc.: Series C $6.3M
Stemgent (Cambridge, MA) a commercial-stage biopharmaceutical company focused on stem cell reagents and tools for stem cell researchers, closed a $6.3M Series C financing. Participants include...
View ArticleClik here to view.
Who’s Still Active Among the Early-Stage Biotech VCs?
Luke Timmerman Imagine for a moment you’re a hotshot biomedical scientist at a university. You have invented a technology in your lab that you think has potential to make a …
View ArticleClik here to view.
Theraclone Secures $14M to Push Antibody Drug Programs
Luke Timmerman Seattle-based Theraclone Sciences has raised another $14 million to support its antibody drug R&D programs. Theraclone said today it has secured $8 million in equity financing and...
View ArticleClik here to view.
Proteostasis, Biogen Team up on Protein Homeostasis Drugs
View the Slideshow Ben Fidler Proteostasis Therapeutics has just gotten some big-name help to try to tackle neurodegenerative diseases like Alzheimer’s and Parkinson’s. Cambridge-based Proteostasis...
View ArticleGlobeImmune Sets $15 to $17 Price Range in Second IPO Attempt
Michael Davidson GlobeImmune has taken a big step forward in its second attempt to go public. Now the question is whether the Louisville, CO-based biotech will get to the finish …
View ArticleGlobeImmune Cuts Size of Pending IPO by 29 Percent
Michael Davidson History might be repeating itself for GlobeImmune, a Colorado-based drug development company that once again appears to be having trouble finding investors for its IPO. GlobeImmune is …
View ArticleClik here to view.
Vaxxas Gets $20M Injection to Test Needle-Free Vaccines in Humans
Ben Fidler What’s the worst part of getting vaccinated? Most folks, outside of the anti-vaccination crowd, would probably say the needle prick. A startup named Vaxxas is one of (Read more...)
View Article
